SMDX - ETF AI Analysis
Top Page
Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX)
Rating:70Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Broad Sector Diversification
Holdings are spread across many sectors, which helps reduce the impact if any single industry runs into trouble.
Multiple Strong Top Holdings
Several of the largest positions, especially in areas like food distribution, health care, and logistics, have shown strong performance, supporting the fund’s overall results.
Negative Factors
Heavy U.S. Concentration
Almost all assets are invested in U.S. companies, offering very limited geographic diversification.
Mixed Results Among Top Holdings
A few key positions, including a real estate services firm and an engineering company, have shown weak performance, which can drag on returns.
Moderate Expense Ratio
The fund’s fees are not especially low for an ETF, which slightly reduces the net return investors keep over time.
SMDX vs. SPDR S&P 500 ETF (SPY)
AUM135.01M
RegionNorth America
Expense Ratio0.35%
Beta0.84
IssuerIntech ETFs
Inception DateFeb 27, 2025
Dividend Yield0.5%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume36
30 Day Avg. Volume122
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
32.10Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering526
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SMDX Summary
SMDX is the Intech S&P Small-Mid Cap Diversified Alpha ETF, an actively managed fund that focuses on smaller and mid-sized U.S. companies in the S&P 1000 index. It spreads investments across many sectors, including industrials, technology, finance, and health care. Well-known holdings include Jones Lang LaSalle and United Therapeutics. Investors might consider SMDX for growth potential outside the big, familiar large-cap names and for added diversification in their portfolio. However, because it focuses on smaller companies, the ETF’s price can be more volatile and can go up and down sharply with the market.
How much will it cost me?The expense ratio for the Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX) is 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized strategy to select stocks with growth potential.
What would affect this ETF?The SMDX ETF, which focuses on small- to mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as smaller companies often have higher borrowing costs, or if economic uncertainty impacts consumer spending and industrial activity. Its focus on U.S. markets also makes it sensitive to domestic regulatory changes and geopolitical events.
SMDX Top 10 Holdings
SMDX leans into U.S. small- and mid-cap names, with industrials and health care acting as key engines. Tenet Healthcare and Exelixis have been rising steadily, giving the fund a healthy boost, while XPO’s strong year-to-date run adds extra horsepower despite some recent bumps. East West Bancorp and US Foods are more steady contributors, helping smooth out volatility. On the flip side, Aecom Technology has been lagging, slightly dragging on returns. Overall, the ETF is broadly diversified across sectors but still driven by a handful of standout U.S. growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Jones Lang Lasalle | 1.20% | $1.61M | $16.67B | 29.57% | 79 Outperform | |
| US Foods Holding | 1.04% | $1.39M | $23.55B | 38.79% | 74 Outperform | |
| United Therapeutics | 1.02% | $1.37M | $23.11B | 76.30% | 79 Outperform | |
| East West Bancorp | 0.94% | $1.26M | $18.04B | 33.36% | 79 Outperform | |
| Everpure | 0.93% | $1.25M | $29.93B | 70.88% | 64 Neutral | |
| Tenet Healthcare | 0.90% | $1.21M | $21.11B | 55.99% | 74 Outperform | |
| Aecom Technology | 0.89% | $1.20M | $9.75B | -38.53% | 71 Outperform | |
| Exelixis | 0.87% | $1.17M | $13.40B | 41.57% | 78 Outperform | |
| XPO | 0.85% | $1.15M | $23.72B | 68.40% | 70 Outperform | |
| Lamar Advertising | 0.81% | $1.09M | $16.33B | 34.49% | 72 Outperform |
SMDX Technical Analysis
Positive
―
Price Trends
26.74
Positive
25.94
Positive
24.69
Positive
Market Momentum
0.26
Negative
64.60
Neutral
100.04
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMDX, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.00, equal to the 50-day MA of 26.74, and equal to the 200-day MA of 24.69, indicating a bullish trend. The MACD of 0.26 indicates Negative momentum. The RSI at 64.60 is Neutral, neither overbought nor oversold. The STOCH value of 100.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMDX.
SMDX Peer Comparison
Comparison Results
Performance Comparison
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
27.71
6.02
27.75%
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
SMIZ
Zacks Small/Mid Cap ETF
―
―
―
RNIN
Bushido Capital US SMID Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents